Trade ideas
Dr Reddys Laboratories Ltd. (Favourable risk to reward ratio)Dr Reddys Laboratories Ltd.
Sector: Pharmaceuticals & Drugs
On a monthly & weekly chart script shows a strong bullish trend. This is a stock that is around its 52-week highs and shows a robust trend.
in daily chart price in demand zone with RSI divergence shows accumulation in daily zone....
Dr. Reddy's Laboratories Limited - Long Setup, Move is ON...#DRREDDY trading above Resistance of 5614
Next Resistance is at 5967
Support is at 4986
Here are previous charts:
Chart is self explanatory. Entry, Resistances and Support are mentioned on the chart.
Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
DRREDDY bullish; above 6070 ? - Wednesday 31 Jan.The above information does not constitute investment/trading recommendation and it is purely for educational purpose. Please check the Strategy below...
SWING Trading Strategy:
Position is created, only upon stock closing above the entry price on day closing basis and is held on for 5-10 trading sessions for larger gains (5-10%)
INTRADAY Trading Strategy:
1) Impulse upmove stage: The strong upmove (nearly upto 2% from breakoutprice) happens within five to 15 minutes. "High Risk Traders" buy in hope of another 2% upmove intraday.
"High Risk Traders" patiently wait through the Pullback-Consolidation stage to realize profits. High risk/High reward set up as breakouts may fakeout (reversal)also
2) Pullback-Consolidation stage: After the above "Impulse upmove stage"; the price may then pull back and move sideways (between "Open" price and "High" of the above "Impulse upmove stage").
Safe traders with minimum risk profile wait for a breakout from the consolidation to enter at this stage to relize high profits in the final intraday final "Breakout continuation" stage
3) Breakout continuation: Stocks often in the third stage breaks up above the "High" of the first "Impulse upmove stage" and continue to go higher again.
Both Safe Traders/High Risk Traders book profits at this stage
This do not constitute, financial, investment, trading, or other types of advice or recommendation.
DRREDDY - Dr Reddy's Laboratories Ltd - Longterm - Bullish1. Annual Revenue rose 16.78%, in the last year to Rs 25,725 Crores. Its sector's average revenue growth for the last fiscal year was 8.64%.
2. Annual Net Profit rose 106.52% in the last year to Rs 4,507 Crores. Its sector's average net profit growth for the last fiscal year was 2.34%.
3. Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
4. Interest Coverage Ratio is 51.85, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
5. Price to Earning Ratio is 19.19, lower than its sector PE ratio of 43.
Stock set for a deep plungeDirectional Signal- Double top is a directional signal present on the ADR of the counter. This is a bearish set up. On the other hand the stock has already given a breakout in NSE chart on the right. This is a big divergence.
Fib Analysis- The previous swing analysis is telling me this rally is not to be trusted.
RSI- RSI on the two time frame charts in the bear zone at price resistance is negative.
Conclusion- with the results due on 30th Jan I think this stock is all prepared to take a deep plunge.
Dr Reddys Laboratories Ltd - Long Term Investment IdeaAs per the current market structure and based on supply & demand, the price may reach around 4500 range (Fibonacci level 61.8%) and would get bounce back from there to reach next high. This would work until it does not break the current Higher high level of 5990.
If it breaks the current HH (5990 Level) then it does not work.
DRREDDY | Investment Pick📊 DETAILS
Sector: Pharmaceuticals & Drugs
Mkt Cap: 90,938 cr
Dr. Reddy's Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
TTM PE : 17.87 (Low PE)
Sector PE : 45.28
Beta : 0.49
📚 INSIGHTS
Strong Performer
Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators
9.51% away from 52 week high
Underperformer - Dr Reddys Laboratories down by -0.74% v/s NIFTY 50 down by -0.29% in last 1 month
📈 FINANCIALS
Piotroski Score of 8/9 indicates Strong Financials
Disclaimer: This analysis is for educational purposes only, and I'm not a SEBI registered analyst.
If you found this analysis helpful, I encourage you to like and share it. Your observations and comments are also welcomed below. Your support, likes, follows, and comments motivate me to consistently share valuable insights with you.
🔍 More Analysis & Trade Setups 🔍
For more technical analysis and trade setups, make sure to follow me on TradingView: www.tradingview.com
DRREDDY looks good for swing tradeDRREDDY has recently experienced a significant breakthrough by surpassing a major downtrend trendline. Following this breakthrough, the stock has found support at this trendline, exhibiting resilience during a minor pullback. Impressively, the pullback appears to be reversing, indicating a potential upward momentum.
Given these promising technical signals, the current market conditions suggest an opportune moment for considering an investment in DRREDDY. The combination of the trendline breakout, subsequent support, and signs of a reversal in the pullback could be indicative of a positive trend reversal in the stock. As always, it's essential to conduct thorough research and consider various factors before making any investment decisions.